PATRYS Ltd (PAB) - Cash Flow Conversion Efficiency

Latest as of June 2025: -2.365x

Based on the latest financial reports, PATRYS Ltd (PAB) has a cash flow conversion efficiency ratio of -2.365x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.73 Million ≈ $-1.23 Million USD) by net assets (AU$732.87K ≈ $518.56K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

PATRYS Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how PATRYS Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read PAB current and long-term liabilities for a breakdown of total debt and financial obligations.

PATRYS Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PATRYS Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Augros Cosmetic Packaging SA
PA:AUGR
-0.287x
Iceni Gold Ltd
AU:ICL
-0.017x
Silver Elephant Mining Corp
TO:ELEF
0.045x
Greenlane Holdings Inc
NASDAQ:GNLN
-0.355x
Perrot Duval Holding SA
SW:PEDU
0.023x
Khaitan (India) Limited
NSE:KHAITANLTD
0.011x
Kanger International Bhd
KLSE:0170
-0.041x
Biomind Labs Inc
NEO:BMND
0.025x

Annual Cash Flow Conversion Efficiency for PATRYS Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of PATRYS Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see how much is PATRYS Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$732.87K
≈ $518.56K
AU$-1.77 Million
≈ $-1.26 Million
-2.421x -362.62%
2024-06-30 AU$3.47 Million
≈ $2.46 Million
AU$-1.82 Million
≈ $-1.28 Million
-0.523x +38.08%
2023-06-30 AU$6.84 Million
≈ $4.84 Million
AU$-5.78 Million
≈ $-4.09 Million
-0.845x -30.75%
2022-06-30 AU$13.43 Million
≈ $9.50 Million
AU$-8.68 Million
≈ $-6.14 Million
-0.646x -100.76%
2021-06-30 AU$12.04 Million
≈ $8.52 Million
AU$-3.88 Million
≈ $-2.74 Million
-0.322x +37.06%
2020-06-30 AU$4.88 Million
≈ $3.45 Million
AU$-2.50 Million
≈ $-1.77 Million
-0.512x -2789.46%
2019-06-30 AU$7.30 Million
≈ $5.16 Million
AU$-129.19K
≈ $-91.41K
-0.018x +93.81%
2018-06-30 AU$7.29 Million
≈ $5.16 Million
AU$-2.09 Million
≈ $-1.48 Million
-0.286x +40.32%
2017-06-30 AU$2.66 Million
≈ $1.88 Million
AU$-1.28 Million
≈ $-903.55K
-0.480x -13.93%
2016-06-30 AU$3.64 Million
≈ $2.57 Million
AU$-1.53 Million
≈ $-1.08 Million
-0.421x +59.39%
2015-06-30 AU$3.97 Million
≈ $2.81 Million
AU$-4.11 Million
≈ $-2.91 Million
-1.036x -153.21%
2014-06-30 AU$12.43 Million
≈ $8.80 Million
AU$-5.09 Million
≈ $-3.60 Million
-0.409x -67.78%
2013-06-30 AU$10.77 Million
≈ $7.62 Million
AU$-2.63 Million
≈ $-1.86 Million
-0.244x +19.13%
2012-06-30 AU$12.45 Million
≈ $8.81 Million
AU$-3.75 Million
≈ $-2.66 Million
-0.302x +20.56%
2011-06-30 AU$13.47 Million
≈ $9.53 Million
AU$-5.11 Million
≈ $-3.62 Million
-0.380x +18.00%
2010-06-30 AU$15.23 Million
≈ $10.78 Million
AU$-7.05 Million
≈ $-4.99 Million
-0.463x -13.05%
2009-06-30 AU$17.72 Million
≈ $12.54 Million
AU$-7.26 Million
≈ $-5.14 Million
-0.410x -26.26%
2008-06-30 AU$22.98 Million
≈ $16.26 Million
AU$-7.45 Million
≈ $-5.27 Million
-0.324x --

About PATRYS Ltd

AU:PAB Australia
Market Cap
$6.99 Million
AU$9.88 Million AUD
Market Cap Rank
#27678 Global
#1452 in Australia
Share Price
AU$0.03
Change (1 day)
-3.33%
52-Week Range
AU$0.00 - AU$0.05
All Time High
AU$0.07
About

Patrys Limited, together with its subsidiaries, develops antibody technologies for the treatment of cancer and NETosis-driven inflammatory diseases. It develops PAT-DX1, a small antibody fragment derived from a humanized version of the binding domain from the original mouse deoxymab antibody 3E10; and PAT-DX3 for treating primary and secondary brain cancers, and metastases that are associated wit… Read more